Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Impact of the fracture risk assessment on patient and physician behavior in osteoporosis prevention.

McConaha JL, Berdine HJ, Skomo ML, Laux RV, Higginbotham SK, O'Neil CK.

J Pharm Pract. 2014 Feb;27(1):25-30. doi: 10.1177/0897190013503970. Epub 2013 Oct 9.

PMID:
24108433
2.

Pharmacist-provided quantitative heel ultrasound screening for rural women at risk of osteoporosis.

Naunton M, Peterson GM, Jones G.

Ann Pharmacother. 2006 Jan;40(1):38-44. Epub 2005 Nov 22.

PMID:
16303984
3.

FRAX® counseling for bone health behavior change in women 50 years of age and older.

Dunniway DL, Camune B, Baldwin K, Crane JK.

J Am Acad Nurse Pract. 2012 Jun;24(6):382-9. doi: 10.1111/j.1745-7599.2012.00700.x. Epub 2012 Mar 29.

PMID:
22672490
4.

Compliance with osteoporosis treatment guidelines in postmenopausal women.

Mountjoy CR, Shrader SP, Ragucci KR.

Ann Pharmacother. 2009 Feb;43(2):242-50. doi: 10.1345/aph.1L464. Epub 2009 Feb 5.

PMID:
19196838
5.

Impact of preventive osteoporosis education on patient behavior: immediate and 3-month follow-up.

Kulp JL, Rane S, Bachmann G.

Menopause. 2004 Jan-Feb;11(1):116-9.

PMID:
14716192
6.

Calcium and vitamin D intake influence bone mass, but not short-term fracture risk, in Caucasian postmenopausal women from the National Osteoporosis Risk Assessment (NORA) study.

Nieves JW, Barrett-Connor E, Siris ES, Zion M, Barlas S, Chen YT.

Osteoporos Int. 2008 May;19(5):673-9. Epub 2007 Nov 13.

PMID:
17999024
7.

What is the impact of osteoporosis education and bone mineral density testing for postmenopausal women in a managed care setting?

Rolnick SJ, Kopher R, Jackson J, Fischer LR, Compo R.

Menopause. 2001 Summer;8(2):141-8.

PMID:
11256875
8.

Osteoporosis screening of postmenopausal women in the primary care setting: a case-based approach.

Edwards BJ, Brooks ER, Langman CB.

Gend Med. 2004 Dec;1(2):70-85. Review.

PMID:
16115586
9.

Impact of a pharmacist-directed intervention in postmenopausal women after fracture.

Heilmann RM, Friesleben CR, Billups SJ.

Am J Health Syst Pharm. 2012 Mar 15;69(6):504-9. doi: 10.2146/ajhp110309.

PMID:
22382482
10.

A before-and-after study of fracture risk reporting and osteoporosis treatment initiation.

Leslie WD, Morin S, Lix LM.

Ann Intern Med. 2010 Nov 2;153(9):580-6. doi: 10.7326/0003-4819-153-9-201011020-00007.

PMID:
21041577
11.

A multifaceted intervention to improve treatment of osteoporosis in postmenopausal women with wrist fractures: a cluster randomized trial.

Cranney A, Lam M, Ruhland L, Brison R, Godwin M, Harrison MM, Harrison MB, Anastassiades T, Grimshaw JM, Graham ID.

Osteoporos Int. 2008 Dec;19(12):1733-40. doi: 10.1007/s00198-008-0669-0. Epub 2008 Jul 16.

PMID:
18629567
12.

Osteoporosis screening and education in community pharmacies using a team approach.

MacLaughlin EJ, MacLaughlin AA, Snella KA, Winston TS, Fike DS, Raehl CR.

Pharmacotherapy. 2005 Mar;25(3):379-86.

PMID:
15843285
13.

Evaluation of osteoporosis risk and initiation of a nurse practitioner intervention program in an orthopedic practice.

Seuffert P, Sagebien CA, McDonnell M, O'Hara DA.

Arch Osteoporos. 2016;11:10. doi: 10.1007/s11657-016-0262-7. Epub 2016 Feb 4.

PMID:
26847628
14.

Osteodensitometry in healthy postmenopausal women.

[No authors listed]

Prescrire Int. 2008 Apr;17(94):68-72.

PMID:
18536138
15.

Osteoporosis treatment in postmenopausal women after peripheral fractures: impact of information to general practitioners.

Malochet-Guinamand S, Chalard N, Billault C, Breuil N, Ristori JM, Schmidt J.

Joint Bone Spine. 2005 Dec;72(6):562-6. Epub 2005 Mar 19.

PMID:
15996502
16.
17.

Diagnosis and treatment of osteoporosis.

Sweet MG, Sweet JM, Jeremiah MP, Galazka SS.

Am Fam Physician. 2009 Feb 1;79(3):193-200. Review.

18.

Bone health management in prostate cancer patients receiving androgen deprivation therapy.

Dhanapal V, Reeves DJ.

J Oncol Pharm Pract. 2012 Mar;18(1):84-90. doi: 10.1177/1078155211402105. Epub 2011 Aug 1.

PMID:
21807761
19.

Effect of 12 months of whole-body vibration therapy on bone density and structure in postmenopausal women: a randomized trial.

Slatkovska L, Alibhai SM, Beyene J, Hu H, Demaras A, Cheung AM.

Ann Intern Med. 2011 Nov 15;155(10):668-79, W205. doi: 10.7326/0003-4819-155-10-201111150-00005. Erratum in: Ann Intern Med. 2011 Dec 20;155(12):860.

PMID:
22084333
20.

The impact of educational interventions on modifiable risk factors for osteoporosis after a fragility fracture.

Beaudoin C, Bessette L, Jean S, Ste-Marie LG, Brown JP.

Osteoporos Int. 2014 Jul;25(7):1821-30. doi: 10.1007/s00198-014-2618-4. Epub 2014 Feb 12.

PMID:
24519745

Supplemental Content

Support Center